Literature DB >> 20533994

Stimulated dopamine overflow and alpha-synuclein expression in the nucleus accumbens core distinguish rats bred for differential ethanol preference.

Anssi Pelkonen1, Mikko Hiltunen, Kalervo Kiianmaa, Leonid Yavich.   

Abstract

The key neurochemical systems and structures involved in the predisposition to substance abuse and preference to ethanol (EtOH) are not known in detail but clearly dopamine (DA) is an important modulator of addiction. Recent data indicate that alpha-synuclein (alpha-syn), a pre-synaptic protein, plays a role in regulation of DA release from the pre-synaptic terminals in striatum and the expression of this protein is different after drug abuse or following abstinence. In the present work, we analysed stimulated DA overflow in the dorsal and ventral striatum in EtOH naïve alko alchohol (AA) and alko non-alchohol (ANA) rats selected for more than 100 generations for their differential EtOH preference. In the same structures, we studied the expression of alpha-syn using western blotting. AA rats, in comparison with ANA rats, showed a marked reduction of stimulated peak DA overflow and higher levels of alpha-syn in the nucleus accumbens core. In the same structure, DA re-uptake was increased in AA rats in comparison with ANA rats. The effects of EtOH at low (0.1 g/kg) and higher (3 mg/kg) doses on DA overflow measured in the nucleus accumbens shell were similar in both lines. These results indicate that high expression of alpha-syn may contribute to the reduced DA overflow and the possible activation of re-uptake in the nucleus accumbens core of AA rats in comparison with ANA rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20533994     DOI: 10.1111/j.1471-4159.2010.06844.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Frequency-dependent effects of ethanol on dopamine release in the nucleus accumbens.

Authors:  Jordan T Yorgason; Mark J Ferris; Scott C Steffensen; Sara R Jones
Journal:  Alcohol Clin Exp Res       Date:  2013-10-11       Impact factor: 3.455

2.  Mining the nucleus accumbens proteome for novel targets of alcohol self-administration in male C57BL/6J mice.

Authors:  Sara Faccidomo; Katarina S Swaim; Briana L Saunders; Taruni S Santanam; Seth M Taylor; Michelle Kim; Grant T Reid; Vallari R Eastman; Clyde W Hodge
Journal:  Psychopharmacology (Berl)       Date:  2018-03-03       Impact factor: 4.530

3.  An α-synuclein gene (SNCA) polymorphism moderates the association of PTSD symptomatology with hazardous alcohol use, but not with aggression-related measures.

Authors:  Casey R Guillot; Jennifer R Fanning; Tiebing Liang; Adam M Leventhal; Mitchell E Berman
Journal:  J Anxiety Disord       Date:  2014-12-30

Review 4.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

5.  The peripheral dopamine 2 receptor antagonist domperidone attenuates ethanol enhancement of dopamine levels in the nucleus accumbens.

Authors:  James Daniel Obray; Eun Young Jang; Anneke M Klomp; Christina A Small; Aaron P Richardson; Joshua J LeBaron; Jin Gyeom Lee; Jordan T Yorgason; Chae Ha Yang; Scott C Steffensen
Journal:  Alcohol Clin Exp Res       Date:  2022-02-01       Impact factor: 3.455

Review 6.  Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.

Authors:  Bin Peng; Qiang Yang; Rachna B Joshi; Yuancai Liu; Mohammed Akbar; Byoung-Joon Song; Shuanhu Zhou; Xin Wang
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

Review 7.  Alpha-Synuclein in Alcohol Use Disorder, Connections with Parkinson's Disease and Potential Therapeutic Role of 5' Untranslated Region-Directed Small Molecules.

Authors:  Catherine M Cahill; Rozaleen Aleyadeh; Jin Gao; Changning Wang; Jack T Rogers
Journal:  Biomolecules       Date:  2020-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.